NEWMARK GROUP INC-CLASS A (NMRK)

US65158N1028 - Common Stock

9.9392  -0.04 (-0.41%)

Buy % Consensus

76

ChartMill assigns a Buy % Consensus number of 76% to NMRK. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 12.37. This target is 24.43% above the current price.
NMRK was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about NMRK.
In the previous month the buy percentage consensus was at a similar level.
NMRK was analyzed by 10 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 9.9411.3612.3712.3713.65 - 14.32% 24.43% 24.43% 37.33%
Up and Down Grades
Date Firm Action Rating
2024-03-26 Piper Sandler Maintains Overweight -> Overweight
2024-02-26 Keefe, Bruyette & Woods Maintains Market Perform -> Market Perform
2023-12-20 Piper Sandler Upgrade Neutral -> Overweight
2023-10-04 Raymond James Downgrade Outperform -> Market Perform
2023-05-09 Goldman Sachs Maintains Sell
2023-05-08 Keefe, Bruyette & Woods Maintains Market Perform
2023-05-08 Raymond James Maintains Outperform
2023-05-08 Piper Sandler Maintains Neutral
2023-04-24 Keefe, Bruyette & Woods Maintains Market Perform
2023-04-11 Goldman Sachs Maintains Sell
2023-04-10 Goldman Sachs Maintains Sell
2023-02-17 Goldman Sachs Maintains Sell
2023-01-20 Raymond James Maintains Outperform
2022-12-12 Goldman Sachs Downgrade Neutral -> Sell
2022-11-08 Goldman Sachs Maintains Neutral
2022-10-31 Raymond James Maintains Outperform
2022-10-20 Raymond James Maintains Outperform
2022-10-19 Goldman Sachs Maintains Neutral
2022-10-07 Piper Sandler Maintains Neutral
2022-07-22 Raymond James Maintains Outperform
2022-04-26 Raymond James Maintains Outperform
2022-04-18 Piper Sandler Downgrade Overweight -> Neutral
2022-03-10 Wolfe Research Downgrade Outperform -> Peer Perform
2021-11-08 Raymond James Maintains Outperform
2021-08-09 Raymond James Maintains Outperform
2021-06-15 Wolfe Research Initiate Outperform
2021-02-19 Goldman Sachs Maintains Buy
2021-02-19 Piper Sandler Upgrade Neutral -> Overweight